Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104609 · ClinicalTrials.gov registry record
Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 26
- Enrollment target
NCT02104609: Completed study, sponsored by University of Southern California.
NCT02104609 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02104609 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of obesity on the pharmacokinetics of the levonorgestrel (LNG) only emergency contraceptive (EC) regimen and on markers of ovulation Primary hypothesis: 1\) Obese users of LNG-EC have a pharmacokinetic profile that is consistent with a larger volume of distribution of LNG. Secondary hypothesis: 1. Alterations in these pharmacokinetic parameters of the LNG-EC regimen in obese women affect the primary mechanism of action, which is inhibition of ovulation. 2. Obesity may affect other factors that alter levels of LNG, such as sex-hormone binding globulin (SHBG) and albumin, which bind LNG and potentially lowers the amount of free LNG.
Interventions
- DRUG Levonorgestrel 1.5mg by mouth once
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-05 |
What the finished NCT02104609 record still lists
NCT02104609 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel 1.5mg by mouth once is the first listed.
NCT02104609 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02104609 about?
NCT02104609 is a clinical study titled "Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill". The purpose of this study is to determine the effects of obesity on the pharmacokinetics of the levonorgestrel (LNG) only emergency contraceptive (EC) regimen and on markers of ovulation Primary hypothesis: 1\) Obese users of LNG-EC have a pharmacokinetic profile that is consistent with a larger v...
What is the current status of trial NCT02104609?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2013-04. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02104609?
The interventions under investigation include: Levonorgestrel 1.5mg by mouth once (DRUG).
Who is sponsoring clinical trial NCT02104609?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia